CLINICAL_TRIALS
trial_result
· 2013-09-02
Clinical Trial Update: The Effect of Nebulized Albuterol on Donor Oxygenation [Phase 2]
Summary
A Phase 2 trial evaluated nebulized albuterol to improve oxygenation in brain-dead organ donors, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt University Medical Center | Conditions: Brain Death, Organ Donor | Phase 2 | Status: COMPLETED | Results posted: 2013-09-02